Growing incidences of gene-related disorders and the rising awareness among patients about early diagnosis to drive the preimplantation genetic testing market in the forecast period, 2023-2027.
According to TechSci Research report, “Preimplantation Genetic Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global preimplantation genetic testing market is anticipated to grow at a significant rate in the forecast period, 2023-2027. The growing occurrences of genetic disorders, the increasing awareness among patients about early diagnosis of genetic diseases, and extensive development in the field of in the field of genetic analysis are the primary factors driving the demand for the global preimplantation genetic testing market. The rise in demand for biopsy procedures, growing medical tourism, increasing number of fertility clinics, rising healthcare expenditure, growing infertility issues among men and women, and high demand of in vitro fertilization treatments are expected to influence the market demand. Also, the growing adoption of inorganic growth strategies such as partnerships, collaborations, and product launches undertaken by the market players are driving the growth of the preimplantation genetic testing market, globally.
However, the risk of infectious diseases being undiscovered, ethical acceptability of PGT services and non-availability of embryos for transfer may hamper the growth of the global preimplantation genetic testing market.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on “Preimplantation Genetic Testing Market”
The global preimplantation genetic testing market is segmented into component, technology, application, end user, and company.
Based on component, the market is divided into reagents & consumables, kits, and services. The reagents & consumables segment is expected to hold the largest market share. This is attributed to the rise in applications of specific technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), in-situ hybridization, and others.
Based on technology, the market is divided into next-generation sequencing (NGS), polymerase chain reaction (PCR), in-situ hybridization, and microarray. The next-generation sequencing segment is anticipated to grow during the forecast period. This is attributed to its capability to detect mosaicism, and low cost.
Based on application, the market is divided into single gene disorder, aneuploidy, structural chromosomal abnormalities, and others. The aneuploidy segment is anticipated to grow during the forecast period. This is attributed to the growing occurrences of aneuploidy and increasing maternal age.
Based on end user, the market is divided into diagnostic center, research center, and others. The diagnostic center segment is anticipated to grow during the forecast period. This is attributed to the high treatment success rate.
Major companies operating in global preimplantation genetic testing market are:
- Illumina, Inc.
- PerkinElmer, Inc.
- Thermo Fischer Scientific, Inc.
- Natera, Inc.
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Invitae Corporation
- Myriad Genetics, Inc.
- MedGenome Labs Ltd.
- Fulgent Genetics, Inc.
Customers can also request for 10% free customization on this report.
“North America region dominates the market in 2021 and is expected to maintain its dominance in the coming years due to the large number of late pregnancy cases. The highest rate of births caused by assisted reproductive technology, the amount of money spent on health care, rising number of IVF procedures and favorable government initiatives in the healthcare sector in the region are another key factor. Also, a growing awareness of the importance of healthy embryos in the region are expected to propel the global preimplantation genetic testing market growth till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Preimplantation Genetic Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component (Reagents & Consumables, Kits, Services), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarray), By Application (Single Gene Disorder, Aneuploidy, Structural Chromosomal Abnormalities, Others), By End User (Diagnostic Center, Research Center, Others), By company and By Region”, has evaluated the future growth potential of global preimplantation genetic testing market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global preimplantation genetic testing market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com
